Africa's defence technology sector is experiencing a quiet but significant inflection point. Terra Industries, a Nigerian startup, is transitioning from civilian drone applications into weaponized systems for the Nigerian military, marking a pivotal moment for the continent's emerging defence-industrial complex. For European investors tracking opportunities across African markets, this development carries both strategic opportunity and considerable complexity. Terra's shift toward combat-ready systems represents a natural progression for African tech entrepreneurs seeking higher-margin, mission-critical applications. The Nigerian military faces sustained pressure from non-state armed groups, particularly in the northeast, creating genuine demand for domestically-produced surveillance and strike capabilities. By developing indigenous solutions, Terra addresses both a security imperative and a nationalist preference for locally-controlled defence infrastructure—a pattern increasingly common across African governments seeking reduced dependency on Western military suppliers. The timing intersects with broader continental trends. African defence spending has grown approximately 4-5% annually over the past decade, with Nigeria alone accounting for roughly one-third of sub-Saharan Africa's military expenditure. However, most procurement remains heavily dependent on foreign imports, creating supply chain vulnerabilities and foreign exchange pressures. Homegrown alternatives like Terra's systems could reshape this calculus, particularly if they demonstrate cost-effectiveness and reliability comparable to established international vendors. For European investors,
Gateway Intelligence
European investors should monitor—but not yet commit significant capital to—African defence-tech startups without comprehensive due diligence on end-use controls, export compliance frameworks, and geopolitical exposure. Consider instead indirect exposure through European companies providing dual-use components (sensors, materials, software platforms) to African militech firms, which offers market participation with reduced regulatory friction. The sector will mature significantly over 5-7 years; patient capital positioning for Series B/C rounds (2026-2028) likely presents better risk-adjusted entry points than current early-stage opportunities.